Correlation Engine 2.0
Clear Search sequence regions


  • DRD2 (11)
  • female (1)
  • GnRH (4)
  • humans (1)
  • ovary (2)
  • PRL (3)
  • profiles (1)
  • protein human (1)
  • receptor 2 (2)
  • receptors (2)
  • women (1)
  • Sizes of these terms reflect their relevance to your search.

    Polycystic ovarian syndrome (PCOS) is a disorder with a foundation of neuroendocrine dysfunction, characterized by increased gonadotropin-releasing hormone (GnRH) pulsatility, which is antagonized by dopamine. The dopamine receptor 2 (DRD2), encoded by the DRD2 gene, has been shown to mediate dopamine's inhibition of GnRH neuron excitability through pre- and post-synaptic interactions in murine models. Further, DRD2 is known to mediate prolactin (PRL) inhibition by dopamine, and high blood level of PRL have been found in more than one third of women with PCOS. We recently identified PRL as a gene contributing to PCOS risk and reported DRD2 conferring risk for type 2 diabetes and depression, which can both coexist with PCOS. Given DRD2 mediating dopamine's action on neuroendocrine profiles and association with metabolic-mental states related to PCOS, polymorphisms in DRD2 may predispose to development of PCOS. Therefore, we aimed to investigate whether DRD2 variants are in linkage to and/or linkage disequilibrium (i.e., linkage and association) with PCOS in Italian families. In 212 Italian families, we tested 22 variants within the DRD2 gene for linkage and linkage disequilibrium with PCOS. We identified five novel variants significantly linked to the risk of PCOS. This is the first study to identify DRD2 as a risk gene in PCOS, however, functional studies are needed to confirm these results. © 2023. BioMed Central Ltd., part of Springer Nature.

    Citation

    Mutaz Amin, Nicholas Horst, Claudia Gragnoli. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome. Journal of ovarian research. 2023 Aug 10;16(1):158

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37563671

    View Full Text